GOLDMAN SACHS GROUP INC - VYNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

VYNE THERAPEUTICS INC's ticker is VYNEXXXX and the CUSIP is 92941V100. A total of 106 filers reported holding VYNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$278,000
+84.1%
175,624
+92.4%
0.00%–
Q3 2020$151,000–91,266–0.00%–
 Download
Other shareholders

There were no reported owners of VYNE THERAPEUTICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of VYNE THERAPEUTICS INC shareholders